Related Experiment Video

Updated: Oct 9, 2026

Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
04:22

Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles

Published on: May 20, 2024

High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease

K Yamagata1, K Urakami, K Ikeda

  • 1Division of Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago, Japan.

Dementia and Geriatric Cognitive Disorders
|February 15, 2001
PubMed

Insights

Alzheimer

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Alzheimer's disease (AD) is a progressive dementia.
  • Apolipoprotein E (apoE) gene expression is implicated in AD pathogenesis.
  • Understanding apoE's role is crucial for AD research.

Purpose of the Study:

  • To investigate apolipoprotein E (apoE) gene expression in Alzheimer's disease (AD) patients.
  • To determine the relationship between apoE genotype, promoter polymorphisms, and apoE mRNA levels in AD.
  • To explore the potential role of elevated apoE mRNA in AD development.

Main Methods:

  • Gene expression analysis using reverse transcriptase-polymerase chain reaction (RT-PCR) to quantify apoE mRNA levels.
  • Genotyping of apoE and promoter polymorphisms (-491A/T, Th1/E47cs) via PCR restriction fragment length polymorphism.
  • Comparison of apoE mRNA levels between AD patients and control groups.

Main Results:

  • Significantly higher apoE mRNA levels were observed in the brains of AD patients compared to controls (p < 0.05).
  • Elevated apoE mRNA levels were also found in AD patients carrying the apoE epsilon 4 allele compared to controls with the same allele (p < 0.05).
  • No significant modulation of apoE mRNA levels by the studied promoter polymorphisms was detected.

Conclusions:

  • Elevated apoE mRNA levels in Alzheimer's disease, particularly in individuals with the apoE epsilon 4 allele, may be a key factor in disease development.
  • Further research is warranted to elucidate the precise mechanisms by which increased apoE mRNA contributes to AD progression.
  • The findings highlight apoE as a potential therapeutic target in Alzheimer's disease management.

More Related Videos

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...